Cargando…
Role of Vitrectomy in Nontractional Refractory Diabetic Macular Edema
Background: Currently, the gold standard of diabetic macular edema (DME) treatment is anti-vascular endothelial growth factor (VEGF) injections, although a percentage of patients do not respond optimally. Vitrectomy with or without internal limiting membrane (ILM) peeling is a well-established treat...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10056256/ https://www.ncbi.nlm.nih.gov/pubmed/36983298 http://dx.doi.org/10.3390/jcm12062297 |
_version_ | 1785016080652042240 |
---|---|
author | Ranno, Stefano Vujosevic, Stela Mambretti, Manuela Metrangolo, Cristian Alkabes, Micol Rabbiolo, Giovanni Govetto, Andrea Carini, Elisa Nucci, Paolo Radice, Paolo |
author_facet | Ranno, Stefano Vujosevic, Stela Mambretti, Manuela Metrangolo, Cristian Alkabes, Micol Rabbiolo, Giovanni Govetto, Andrea Carini, Elisa Nucci, Paolo Radice, Paolo |
author_sort | Ranno, Stefano |
collection | PubMed |
description | Background: Currently, the gold standard of diabetic macular edema (DME) treatment is anti-vascular endothelial growth factor (VEGF) injections, although a percentage of patients do not respond optimally. Vitrectomy with or without internal limiting membrane (ILM) peeling is a well-established treatment for DME cases with a tractional component while its role for nontractional cases is unclear. The aim of this study is to evaluate the role of vitrectomy with or without ILM peeling in nontractional refractory DME. Methods: We performed a retrospective review of twenty-eight eyes with nontractional refractory DME treated with vitrectomy at San Giuseppe Hospital, Milan, between 2016 and 2018. All surgeries were performed by a single experienced vitreoretinal surgeon. In 43.4% of cases, the ILM was peeled. Best corrected visual acuity and optical coherence tomography (OCT) scans were assessed preoperatively and at 6, 12, and 24 months post-vitrectomy. Results: The mean central macular thickness improved from 413.1 ± 84.4 to 291.3 ± 57.6 μm at two years (p < 0.0001). The mean logarithm of the minimum angle of resolution logMAR best-corrected visual acuity (BCVA) improved after two years, from 0.6 ± 0.2 to 0.2 ± 0.1 (p < 0.0001). We found no difference between ILM peeling vs. no ILM peeling group in terms of anatomical (p = 0.8) and visual outcome (p = 0.3). Eyes with DME and subfoveal serous retinal detachment (SRD) at baseline had better visual outcomes at the final visit (p = 0.001). Conclusions: We demonstrated anatomical and visual improvement of patients who underwent vitrectomy for nontractional refractory DME with and without ILM peeling. Improvement was greater in patients presenting subretinal fluid preoperatively. |
format | Online Article Text |
id | pubmed-10056256 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-100562562023-03-30 Role of Vitrectomy in Nontractional Refractory Diabetic Macular Edema Ranno, Stefano Vujosevic, Stela Mambretti, Manuela Metrangolo, Cristian Alkabes, Micol Rabbiolo, Giovanni Govetto, Andrea Carini, Elisa Nucci, Paolo Radice, Paolo J Clin Med Brief Report Background: Currently, the gold standard of diabetic macular edema (DME) treatment is anti-vascular endothelial growth factor (VEGF) injections, although a percentage of patients do not respond optimally. Vitrectomy with or without internal limiting membrane (ILM) peeling is a well-established treatment for DME cases with a tractional component while its role for nontractional cases is unclear. The aim of this study is to evaluate the role of vitrectomy with or without ILM peeling in nontractional refractory DME. Methods: We performed a retrospective review of twenty-eight eyes with nontractional refractory DME treated with vitrectomy at San Giuseppe Hospital, Milan, between 2016 and 2018. All surgeries were performed by a single experienced vitreoretinal surgeon. In 43.4% of cases, the ILM was peeled. Best corrected visual acuity and optical coherence tomography (OCT) scans were assessed preoperatively and at 6, 12, and 24 months post-vitrectomy. Results: The mean central macular thickness improved from 413.1 ± 84.4 to 291.3 ± 57.6 μm at two years (p < 0.0001). The mean logarithm of the minimum angle of resolution logMAR best-corrected visual acuity (BCVA) improved after two years, from 0.6 ± 0.2 to 0.2 ± 0.1 (p < 0.0001). We found no difference between ILM peeling vs. no ILM peeling group in terms of anatomical (p = 0.8) and visual outcome (p = 0.3). Eyes with DME and subfoveal serous retinal detachment (SRD) at baseline had better visual outcomes at the final visit (p = 0.001). Conclusions: We demonstrated anatomical and visual improvement of patients who underwent vitrectomy for nontractional refractory DME with and without ILM peeling. Improvement was greater in patients presenting subretinal fluid preoperatively. MDPI 2023-03-15 /pmc/articles/PMC10056256/ /pubmed/36983298 http://dx.doi.org/10.3390/jcm12062297 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Brief Report Ranno, Stefano Vujosevic, Stela Mambretti, Manuela Metrangolo, Cristian Alkabes, Micol Rabbiolo, Giovanni Govetto, Andrea Carini, Elisa Nucci, Paolo Radice, Paolo Role of Vitrectomy in Nontractional Refractory Diabetic Macular Edema |
title | Role of Vitrectomy in Nontractional Refractory Diabetic Macular Edema |
title_full | Role of Vitrectomy in Nontractional Refractory Diabetic Macular Edema |
title_fullStr | Role of Vitrectomy in Nontractional Refractory Diabetic Macular Edema |
title_full_unstemmed | Role of Vitrectomy in Nontractional Refractory Diabetic Macular Edema |
title_short | Role of Vitrectomy in Nontractional Refractory Diabetic Macular Edema |
title_sort | role of vitrectomy in nontractional refractory diabetic macular edema |
topic | Brief Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10056256/ https://www.ncbi.nlm.nih.gov/pubmed/36983298 http://dx.doi.org/10.3390/jcm12062297 |
work_keys_str_mv | AT rannostefano roleofvitrectomyinnontractionalrefractorydiabeticmacularedema AT vujosevicstela roleofvitrectomyinnontractionalrefractorydiabeticmacularedema AT mambrettimanuela roleofvitrectomyinnontractionalrefractorydiabeticmacularedema AT metrangolocristian roleofvitrectomyinnontractionalrefractorydiabeticmacularedema AT alkabesmicol roleofvitrectomyinnontractionalrefractorydiabeticmacularedema AT rabbiologiovanni roleofvitrectomyinnontractionalrefractorydiabeticmacularedema AT govettoandrea roleofvitrectomyinnontractionalrefractorydiabeticmacularedema AT carinielisa roleofvitrectomyinnontractionalrefractorydiabeticmacularedema AT nuccipaolo roleofvitrectomyinnontractionalrefractorydiabeticmacularedema AT radicepaolo roleofvitrectomyinnontractionalrefractorydiabeticmacularedema |